Michael V. McConnell et al. JACC 2018;71:

Slides:

Advertisements

Similar presentations

Alan Rozanski et al. JACC 2005;45:

Advertisements

Michala E.F. Pedersen et al. JACEP 2017;3:

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Noriko Kikuchi et al. JACEP 2016;2:

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Waddah Maskoun et al. JACEP 2016;2:

Daniel Frenkel et al. JACEP 2016;2:

Patrizio Lancellotti et al. JIMG 2016;9:

Shadi Al Halabi et al. JACEP 2015;1:

Dean J. Kereiakes et al. JACC 2017;70:

G. Michael Felker et al. JCHF 2014;2:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Junjie Zhang et al. JACEP 2017;j.jacep

David D. Berg et al. JACC 2018;71:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

S.M. Afzal Sohaib et al. JACEP 2015;1:

Johannes Steiner et al. JACC 2017;70:

Junjie Zhang et al. JACEP 2017;3:

Jose C. Pachon M. et al. JACEP 2015;1:

Tom F. Brouwer et al. JACEP 2016;2:

Adam B. Greenbaum et al. JACEP 2015;1:

Simon W. Rabkin et al. JACEP 2017;j.jacep

Dhanunjaya Lakkireddy et al. JACEP 2015;1:

Wesley T. O’Neal et al. JACEP 2016;2:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Michala E.F. Pedersen et al. JACEP 2016;j.jacep

Stavros Stavrakis et al. JACEP 2015;1:1-13

Mohit K. Turagam et al. JACEP 2017;3:

Moussa Mansour et al. JACEP 2017;3:

M. Rizwan Afzal et al. JACEP 2017;3:

Khurram Nasir et al. JACC 2015;66:

Mintu P. Turakhia et al. JACEP 2016;2:

Matthew Oster et al. JACC 2019;73:

The procedural journey for our cohort of patients with persistent atrial fibrillation. The procedural journey for our cohort of patients with persistent.

K.R. Julian Chun et al. JACEP 2017;3:

G. Michael Felker et al. JCHF 2014;2:

Figure 9 Management of atrial fibrillation

Nicolaj C. Hansson et al. JACC 2016;68:

Shahrokh Javaheri et al. JACC 2017;69:

Moussa Mansour et al. JACEP 2016;j.jacep

Peter E. Carson et al. JCHF 2015;3:

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Pamela E. Scott et al. JACC 2018;71:

Simon W. Rabkin et al. JACEP 2017;3:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Volume 8, Issue 1, Pages (January 2011)

Jose C. Pachon M. et al. JACEP 2015;1:

Miyako Igarashi et al. JACEP 2018;4:

Receiver operating characteristics curve of N-terminal pro-atrial natriuretic peptide plasma levels (dark line) and brain natriuretic peptide (dashed line)

Nat. Rev. Cardiol. doi: /nrcardio

Michael V. McConnell et al. JACC 2018;71:

Michael V. McConnell et al. JACC 2018;71:

Jeffrey L. Anderson et al. JACC 2007;50:e1-e157

Glenn N. Levine et al. JACC 2011;58:e44-e122

Potential effect of guidelines on ASCVD prevention in the CGPS*

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Ryan R. Reeves et al. JCIN 2015;8:

OPN is elevated in patients with symptomatic AS

Vallerie V. McLaughlin et al. JACC 2009;53:

Pharmacological management of patients with newly discovered atrial fibrillation. Pharmacological management of patients with newly discovered atrial fibrillation.

Rick A. Nishimura et al. JACC 2017;70:

Pharmacological management of patients with recurrent paroxysmal atrial fibrillation. Pharmacological management of patients with recurrent paroxysmal.

Zeenat Safdar et al. JCHF 2014;2:

Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation. Pharmacological management of patients with recurrent.

Orly Vardeny et al. JCHF 2016;4:

Maria R. Costanzo et al. JCHF 2016;4:

Gianluigi Savarese et al. JCHF 2016;4:

Forest plot of all-cause mortality (ACM) in CRT patient with AF comparing atrioventricular junction ablation (AVJA) versus no AVJA. AF, atrial fibrillation;

Stefan Toggweiler et al. JCIN 2016;9:

Presentation transcript:

Michael V. McConnell et al. JACC 2018;71:2691-2701 Mobile Health for Physical Activity and Atrial Fibrillation Cardiovascular mobile health starts with the patient in the center. The two main areas reviewed in the paper are physical activity monitoring for health promotion and prevention plus heart rhythm monitoring for atrial fibrillation detection and management. The left silhouette presents a woman walking with her phone, with the phone screen congratulating her for achieving her weekly American College of Cardiology/American Heart Association/World Health Organization physical activity guidance of 150 min. The right silhouette presents a patient sitting and taking an electrocardiogram with a smartwatch, with the watch screen showing heart rate (HR) and electrocardiogram waveforms of atrial fibrillation. The health care team and family and social network are shown in 2-way communication with the patient and his or her mobile health data. Michael V. McConnell et al. JACC 2018;71:2691-2701 2018 American College of Cardiology Foundation